BSEUnipro Technologies LtdMediumNeutral
Announced Sat, 29 Nov · 18:36 IST

Disclosure

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Unipro Technologies Ltd has appointed Dr. William Peddapanga (DIN: 10302568) as an Additional Director in a Non-Executive, Independent capacity for a 5-year term, from November 29, 2025 to November 28, 2030, subject to shareholder approval. Dr. Peddapanga is a medical professional with over a decade of experience in healthcare and hospital management, and he is the Founder and Managing Director of Aadhya's Life Line Hospital in Hyderabad. He holds 13,770 equity shares in the company and is not related to any existing director, KMP, or promoter. The appointment was made on the recommendation of the Nomination and Remuneration Committee, and the company has confirmed he is not debarred by SEBI or any other authority.

Likely market impact

This is a routine board strengthening move that brings independent healthcare expertise to the board. It is unlikely to have a material near-term impact on the stock price, though shareholder approval will be required at the next general meeting.